Allstate trades at a very low 5.35x TTM P/E with robust profitability (net margin 17.8%, operating margin 19.0%), exceptional capital efficiency (ROE 45.2%), and conservative valuation metrics (P/S 0.91, EV/Revenue 1.04). Earnings rebounded strongly (EPS growth +338% YoY), and beta is low (0.166). Given improving underwriting results and pricing, intrinsic value appears well above the current price, offering attractive long-term upside and diversification benefits versus our tech holdings.
While Allstate appears optically cheap with a trailing P/E of 5.54, its forward P/E of 9.9 indicates that earnings are expected to decline sharply. This is typical of cyclical peak earnings in the P&C insurance sector. Selling to avoid a value trap and reallocate capital into a superior wide-moat compounder.
Allstate trades at a very low 5.35x TTM P/E with robust profitability (net margin 17.8%, operating margin 19.0%), exceptional capital efficiency (ROE 45.2%), and conservative valuation metrics (P/S 0.91, EV/Revenue 1.04). Earnings rebounded strongly (EPS growth +338% YoY), and beta is low (0.166). Given improving underwriting results and pricing, intrinsic value appears well above the current price, offering attractive long-term upside and diversification benefits versus our tech holdings.
While Allstate appears optically cheap with a trailing P/E of 5.54, its forward P/E of 9.9 indicates that earnings are expected to decline sharply. This is typical of cyclical peak earnings in the P&C insurance sector. Selling to avoid a value trap and reallocate capital into a superior wide-moat compounder.
+5.2% vs S&P 500 · 20 sessions
Window: 20 trading sessions from the later decision (Jul 16, 2026). Returns are price returns against SPY (unadjusted). Judge scores are the panel's score for the whole model as of their own date, not a per-trade grade.
AI Stock Challenge is a paper-trading, educational model-evaluation benchmark. Nothing here is investment advice.